Grace Therapeutics, Inc. (GRCE)
SG&A Expenses
$7.45M
TTM · Period ending: · USD
GRCE SG&A Expenses
Latest reported$7.45Mperiod ending
Latest reported$7.45Mperiod ending
GRCE SG&A Expenses ($549.74K → $7.45M)
Annual SG&A Expenses
High-resolution chart · PNG
GRCE sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 8,665,000 | |
| 10,198,051 | |
| 9,015,974 | |
| 11,106,990 | |
| 12,221,098 | |
| 10,502,625 | |
| 16,912,715 | |
| 4,292,000 | |
| 3,118,297 | |
| 768,742 | |
| 1,509,840 | |
| 2,855,727 | |
| 4,448,274 | |
| 4,189,052 | |
| 3,549,866 | |
| 1,644,936 | |
| 408,589 | |
| 549,743 |